REDCap Cloud Launches Next-Generation Clinical Trial Data and Analytics Platform to Power AI-Driven Research

REDCap Cloud harmonizes real-world evidence and trial data to overcome the industry’s biggest data management challenges; lays the foundation for AI-driven research

15 September 2025 -- Florida, US -- nPhase, Inc., an innovator of cloud-based clinical research technology, today launched REDCap Cloud 2.0, the first industry platform to harmonize real-world evidence and clinical trial data in one system. With an interoperable architecture, the platform addresses the complex data needs of global-scale research while laying the foundation for AI adoption that will transform the future of research innovation and how life sciences organizations design, run, and analyze studies.

As clinical trials grow increasingly complex, companies must manage unprecedented volumes of diverse data. Tufts CSDD research shows that phase 3 trials generate an average of 3.6 million data points, triple the volume collected a decade ago. Real-world evidence and data (RWE/RWD) from patient forms, wearables, electronic health records, and other sources are playing a greater role in research but often come in inconsistent formats with quality gaps. Study teams must reconcile errors, duplications, and missing information while manually transferring data between systems; in fact, 55% of data managers report that reconciling data is one of their biggest burdens today.

REDCap Cloud solves these challenges by unifying disparate data sources and clinical data ecosystems into one platform, giving researchers a reliable, real-time view of trial performance. Featuring open architecture, standards-built data harmonization, and robust security, REDCap Cloud automates workflows, shortens timelines, and delivers clean, reliable, high-quality data. Notably, REDCap Cloud has already proven its effectiveness on an enterprise scale with a top-5 pharmaceutical company in a global deployment to be announced in the coming months.

“For the first time, sponsors can see how a study is performing clinically in near real-time, compressing the ‘white space’ between data collection and scientific review and enabling teams to accomplish in days what previously took months,” said Dave Sunderhaft, COO of REDCap Cloud. “REDCap Cloud 2.0 is not just an upgrade; it’s the platform our industry has been waiting for to unify all clinical data on a standards-based foundation and proving it at enterprise scale.”

Key platform capabilities include:

• True Data Unification – Breaks down silos by combining case report forms and RWE on one platform to deliver a single, consistent data layer for analysis.
• Accelerated Insights – Automated data quality checks, anomaly detection, and issue triage produce analysis-ready datasets faster with auditable lineage.
• Universal Study Support – Flexible architecture scales from single-site pilots to complex Phase I–IV programs and large registries, without requiring the swapping of tools midstream.
• Seamless Study Modifications – Implement protocol amendments without halting operations or jeopardizing compliance, reducing amendment costs and timeline risk.
• Open Architecture – Interoperability with external data sources, third party tools, and partner ecosystems to prevent vendor lock in and support rapid, adaptive designs.

Additionally, with REDCap Cloud’s purpose-built, on-platform advanced analytics capabilities, study teams now operate from a single source of truth, accelerating clinical development and enhancing collaboration across global stakeholders. This marks a tectonic shift for research, empowering researchers with a deeper, more holistic view of patients for more effective drug development and unlocking a capability researchers have never had before: understanding how therapies perform across diverse, real-world populations and disease states in real-time.

Learn more at the annual DPHARM Conference (Philadelphia, PA) Sept 16th, 2025 and at the annual SCDM Conference (Baltimore, MD) on Sept 28th, 2025.

About REDCap Cloud (nPhase, Inc)
REDCap Cloud is an enterprise-grade clinical research data platform that integrates clinical trial and real-world evidence into a unified data layer for clinical decision-making. Purpose-built for life sciences with a foundation in security, compliance and AI-ready infrastructure, researchers can now unlock the full potential of their data. REDCap Cloud is redefining how research data is captured, harmonized, and analyzed across the global healthcare ecosystem. For more information visit www.redcapcloud.com.